Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Inogen Inc    INGN

INOGEN INC

(INGN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news

Inogen : Short seller Carson Block targets medical device company Inogen

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/08/2019 | 11:16am EDT
Carson Block, Chief Investment Officer, Muddy Waters Capital, speaks at the Sohn Investment Conference in New York

BOSTON (Reuters) - Prominent short seller Carson Block is saying that medical device company Inogen Inc has inflated the size of its markets and expects the stock price to fall.

Block, whose research firm Muddy Waters is best known for targeting the shares of China-based companies, has written a new report that asserts that Inogen's management has made overly optimistic growth forecasts.

The company's stock fell 6.2 percent Friday morning to $131.07. It had climbed steadily to as high as $282.92 in September.

Calls to the company's media relations and investor relations departments seeking comment were not returned.

Muddy Waters is short Inogen Inc because it question's Inogen's statements about total addressable market (TAM) size and potential growth, the report seen by Reuters said.

Inogen has a market capitalization of $3 billion and makes lightweight portable oxygen concentrators that free its users from being tethered to heavy tanks.

While the company has said the U.S. TAM is roughly 3 million users and is growing at 7 percent to 10 percent a year, Block said the real U.S. TAM is far smaller at about 1.3 million, citing Centers for Medicare & Medicaid Services (CMS) data. He also said CMS data shows that the oxygen therapy market has been shrinking. He wrote that Inogen based its estimates on data from Wintergreen Research.

"The key to INGN's extreme multiple is its blue sky story," the report said.

Block sees more room for it to fall, arguing that "INGN will hit peak sales as soon as this year, and likely no later than next." Block wrote in the report "At our forecast of peak earnings, we value INGN at $46 per share, a 67 percent decrease

from its current price."

Block ranks among the industry's most closely followed short-sellers, who seek to make money when a stock price falls. Some occasionally publish research reports detailing what they consider to be wrong with a company.

Dedicated short-sellers like Block, whose fund oversees roughly $210 million, tend to manage small amounts of money and often face uphill battles when the stock market is zooming higher.

Last year when Block published three reports, including one on Chinese tutoring company TAL Education Group, his fund earned 20 percent after fees. The Standard & Poor's 500 index fell 4.4 percent and the activist investors on average lost 11.25 percent.

Block, who trained as a lawyer but started his career as an equity analyst, distributed his research for free for years and said it took him years to create his hedge fund, which was launched in 2016.

(Reporting by Svea Herbst-Bayliss; Editing by Steve Orlofsky)

By Svea Herbst-Bayliss

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INOGEN INC
04/17DEADLINE REMINDER : The Law Offices of Howard G. Smith Reminds Investors of Loom..
BU
04/16INOGEN : Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Cl..
BU
04/10SCOTT+SCOTT ATTORNEYS AT LAW LLP : Alerts Investors to Securities Class Actions ..
BU
04/10Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in In..
PR
04/03INOGEN : Releases Innovative Inogen One G5™ Portable Oxygen Concentrator
BU
04/02INOGEN : Hagens Berman Reminds Inogen (INGN) Investors of May 6, 2019 Lead Plain..
PR
03/29INOGEN SHAREHOLDER ALERT BY FORMER L : Kahn Swick & Foti, LLC Reminds Investors ..
BU
03/27INOGEN : Announces Participation in the 18th Annual Needham Healthcare Conferenc..
BU
03/27INGN INVESTORS ALERT : Lieff Cabraser Announces Securities Class Action Against ..
BU
03/26INOGEN : Glancy Prongay & Murray LLP Announces the Filing of a Securities Class ..
BU
More news
Financials ($)
Sales 2019 434 M
EBIT 2019 49,0 M
Net income 2019 44,7 M
Finance 2019 262 M
Yield 2019 -
P/E ratio 2019 44,16
P/E ratio 2020 36,29
EV / Sales 2019 3,64x
EV / Sales 2020 2,90x
Capitalization 1 843 M
Chart INOGEN INC
Duration : Period :
Inogen Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INOGEN INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 164 $
Spread / Average Target 95%
EPS Revisions
Managers
NameTitle
Scott Wilkinson President, Chief Executive Officer & Director
Heath Lukatch Chairman
Bart Sanford Executive Vice President-Operations
Alison K. Bauerlein CFO, Secretary, Treasurer & Executive VP
Brenton Taylor Executive Vice President-Engineering
Sector and Competitors
1st jan.Capitalization (M$)
INOGEN INC-32.32%1 843
MEDTRONIC PLC-6.44%114 132
BAXTER INTERNATIONAL INC.14.33%39 019
HOYA CORPORATION16.91%25 740
ZIMMER BIOMET HOLDINGS18.36%25 114
ALIGN TECHNOLOGY41.37%23 685